Trenbolone
Active Substance: Trenbolone
Description
What is Tren? (Detailed Explanation/Different Names)
Trenbolone is a potent synthetic Anabolic Androgenic Steroid (AAS) belonging to the nandrolone group. It was initially developed for veterinary use, specifically in livestock (cattle), to promote muscle growth, improve feed efficiency, and increase appetite before slaughter.
It is a powerful androgen that does not undergo aromatization (conversion to estrogen) like testosterone, which contributes to some of its unique effects.
Different Names and Forms:
-
Generic Name: Trenbolone (also sometimes referred to as Trienolone or Trienbolone).
-
Common Ester Forms (Prodrugs): To prolong its effective half-life in the body, Trenbolone is administered as an ester conjugate via intramuscular injection:
-
Trenbolone Acetate (TBA): Known by brand names like Finajet or Finaplix (veterinary use). This is the most common form, characterized by a shorter half-life.
-
Trenbolone Enanthate: Often found on the black market under names like Trenabol. It has a longer half-life than the acetate version.
-
Trenbolone Hexahydrobenzylcarbonate: Formerly marketed for human clinical use under the brand name Parabolan or Hexabolan, but is no longer commercially available for human use. This form has the longest half-life.
-
Side Effects and Benefits (Pros and Cons)
Since Trenbolone is not approved for human medical use, its "benefits" primarily refer to its effects as a performance-enhancing drug (PED), while its "side effects" are the numerous, often severe, adverse health reactions.
Dosage and Frequency
Note: There are no medically approved human dosages for Trenbolone. Information on human dosing comes from illicit use and is inherently unreliable and dangerous. The following is based on typical reported black market use:
-
Trenbolone Acetate: Due to its short half-life, users typically inject every day (EOD) or every other day (EOD).
-
Reported common dosage: 50 mg to 150 mg per injection.
-
-
Trenbolone Enanthate: With a longer half-life, users typically inject once or twice per week.
-
Reported common dosage: 200 mg to 400 mg per week, divided into injections.
-
Half-Life and Detection Time
The half-life and detection time vary significantly depending on the ester used:
Note: Detection times for drug testing (doping control) are often longer than the elimination half-life because metabolites of the drug can be detectable in urine for extended periods. Trenbolone metabolites can persist for several weeks.
Sterogenic, Progestronic, and Prolactin Effects
-
Estrogenic Effects (Aromatization):
-
Trenbolone does not undergo aromatization; thus, it does not directly convert to estrogen. This means classic estrogenic side effects like fluid retention and gynecomastia (breast tissue growth) from estrogen conversion are avoided.
-
However, gynecomastia is still a risk due to its other activities (see Progestronic/Prolactin effects).
-
-
Progestronic Effects (Progestin Activity):
-
Trenbolone is a potent progestin, meaning it binds strongly to the progesterone receptor. This is a key feature as it is derived from nandrolone, which is also a progestin.
-
-
Prolactin Effects (Hyperprolactinemia):
-
The combination of high progestin activity and the resulting dopamine suppression can lead to an increase in the hormone prolactin (Hyperprolactinemia).
-
Elevated prolactin, especially when combined with a hormonal imbalance (like suppressed testosterone), can trigger or exacerbate gynecomastia, cause lactation (galactorrhea), and lead to decreased libido and erectile dysfunction (often referred to as 'Deca Dick' or 'Tren Dick').
-
Anabolic Androgenic Ratio
The Anabolic-Androgenic Ratio (AAR) is a metric comparing a steroid's anabolic (muscle-building) effects to its androgenic (male characteristic development) effects, relative to testosterone (which has a ratio of
or ).-
Anabolic-Androgenic Ratio for Trenbolone:
500:500
This ratio, relative to testosterone (
), indicates that Trenbolone is rated as five times (5x) as potent in both anabolic and androgenic activity, making it one of the most powerful AAS available.Pharmacological Properties
Half Life
1 days
Active Dose
87%
Detection
5.00 days
Concentration
250 mg/ml
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
High
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
200-400 mg/week
Intermediate
400-600 mg/week
Advanced
600-800 mg/week
Evidence-based planning resources
Dive deeper into Trenbolone cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Trenbolone compound database overviewCompare Trenbolone with other steroid agents in the structured compound index.
- Trenbolone stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Trenbolone.
- Harm-reduction guide for TrenboloneRefresh safety monitoring, lab work, and countermeasure strategies tailored for Trenbolone protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Trenbolone with trusted clinical databases.
- Trenbolone clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Trenbolone pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Rare
Severe
Safety Information
Liver Toxicity
None
Kidney Toxicity
Moderate
Cardiovascular Risk
High
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.